The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests
Authors
Keywords
-
Journal
Frontiers in Plant Science
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-27
DOI
10.3389/fpls.2021.699665
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
- (2021) Konlavat Siriwattananon et al. Frontiers in Plant Science
- SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients
- (2021) Mohau S. Makatsa et al. Frontiers in Plant Science
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
- (2020) Wanbing Liu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Potential Applications of Plant Biotechnology against SARS-CoV-2
- (2020) Teresa Capell et al. TRENDS IN PLANT SCIENCE
- Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies
- (2020) Marie Tré‐Hardy et al. JOURNAL OF MEDICAL VIROLOGY
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- (2020) Marina Pollán et al. LANCET
- From Farm to Finger Prick—A Perspective on How Plants Can Help in the Fight Against COVID-19
- (2020) Karen A. McDonald et al. Frontiers in Bioengineering and Biotechnology
- Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA
- (2020) Neha Kaushal et al. Pathogens
- Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
- (2020) Jeffrey D. Whitman et al. NATURE BIOTECHNOLOGY
- SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
- (2020) Abdullah Algaissi et al. Scientific Reports
- Immunologic testing for SARS-CoV-2 infection from the antigen perspective
- (2020) Dandan Li et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pilot Production of SARS-CoV-2 Related Proteins in Plants: A Proof of Concept for Rapid Repurposing of Indoor Farms Into Biomanufacturing Facilities
- (2020) Borja Diego-Martin et al. Frontiers in Plant Science
- Innovation in plant-based transient protein expression for infectious disease prevention and preparedness
- (2019) Frank Sainsbury CURRENT OPINION IN BIOTECHNOLOGY
- Development of Systems for the Production of Plant-Derived Biopharmaceuticals
- (2019) Ki-Beom Moon et al. Plants-Basel
- Potential Application of Plant-derived Bioengineered Human VEGF for Tissue Regeneration
- (2016) Williams Laura et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS
- (2016) Olivia C. Demurtas et al. Frontiers in Plant Science
- Plants as Factories for Human Pharmaceuticals: Applications and Challenges
- (2015) Jian Yao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-level production of active human TFPI-2 Kunitz domain in plant
- (2014) Laura Williams et al. PROTEIN EXPRESSION AND PURIFICATION
- The Coronavirus Nucleocapsid Is a Multifunctional Protein
- (2014) Ruth McBride et al. Viruses-Basel
- Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems
- (2010) Gregory P. Pogue et al. PLANT BIOTECHNOLOGY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started